Intra-uterine exposure to maternal opiate abuse and HIV: the impact on the developing nervous system.

Autor: Palchik AB; Department of Neurology, Paediatric Medical Academy St. Petersburg, Russia., Einspieler C, Evstafeyeva IV, Talisa VB, Marschik PB
Jazyk: angličtina
Zdroj: Early human development [Early Hum Dev] 2013 Apr; Vol. 89 (4), pp. 229-35. Date of Electronic Publication: 2013 Mar 11.
DOI: 10.1016/j.earlhumdev.2013.02.004
Abstrakt: Background: Both intra-uterine exposure to maternal drugs and HIV are known to adversely affect the developing central nervous system.
Aims: (1) To describe the quality of GMs in infants who were intra-uterinely exposed to maternal opiate abuse and HIV; and (2) to analyze to what extent (a) perinatal events, (b) status of HIV-infection, and (c) the quality of GMs are associated with the neurodevelopmental outcome at 2 to 3years of age.
Patients and Method: Seventy-seven children intra-uterinely exposed to both maternal opiate abuse and HIV in utero (41 boys and 36 girls; 39 born preterm) were videoed twice: first during the first 2months after term (writhing GMs) and again at 3-5months (fidgety GMs). Neurodevelopmental outcome was assessed at 2-3years of age.
Results: Thirty-eight infants showed abnormal writhing GMs; 25 infants had abnormal or absent fidgety movements; 22 children had an adverse neurodevelopmental outcome. The association between GM trajectories and outcome revealed a Cramer-V=0.75 (p<0.001). Those infants with active HIV-infection (n=10) did not differ from the 67 infants who were HIV-exposed but uninfected with respect to their GM quality or outcome.
Conclusions: Serial assessment of GMs in infants who were intra-uterinely exposed to maternal opiates and to HIV can be utilized for early identification of infants at a higher risk for later deficits and needing early intervention.
(Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.)
Databáze: MEDLINE
Externí odkaz: